Tokyo

London

New York

Register

Sign In

EUR/USD

1.0724

-0.0042

-0.39%

GBP/USD

1.2491

0.0051

0.41%

USD/JPY

111.32

0.2260

0.20%

USD/CHF

0.9976

0.0015

0.15%

EUR/GBP

0.8585

-0.0068

-0.79%

USD/CAD

1.3287

-0.0046

-0.35%

NZD/USD

0.7016

-0.0018

-0.25%

EUR/JPY

119.37

-0.2265

-0.19%

EUR/CHF

1.0698

-0.0026

-0.24%

Cytomx Thera Cmn Stk

NASDAQ: CTMXHealthcare / Biotechnology / USA
16.87-0.13-0.76%Vol 67 3401Y Perf 34.61%
Mar 30th, 2017 12:17
BID16.81 ASK16.88
Open16.96 Previous Close17.00
Pre-Market- After-Trading-
 - -%  - -%
Target Price
26.50 
Analyst Rating
Strong Buy 1.50
Potencial %
56.99 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
—    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
—    -
Market Cap (mil)622 
Earnings Rating
Neutral
Price Range Ratio 52wk %
71.15 
Earnings Date
5th May 2017

Today's Price Range

16.8117.10

 

52wk Range

9.1020.02

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-5.67%
3 Months
-7.32%
6 Months
4.23%
1 Year
34.61%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CTMX16.87-0.1300-0.76
AAPL143.69-0.4300-0.30
GOOG829.96-1.4500-0.17
MSFT65.840.37000.57
XOM82.750.73000.89
WFC56.170.50000.90
JNJ124.76-0.1600-0.13
FB142.43-0.2200-0.15
GE29.910.23000.77
JPM88.810.54000.61
...

TickerPriceChg.%52 Week High
COP49.467.6453.17
FTR2.145.945.75
FCX13.254.1717.06
AA33.983.2539.78
GPN81.333.1781.63
FITB25.742.8028.97
RF14.682.5916.03
ZION42.392.5948.33
KEY17.932.4019.53
CMG444.542.35473.75
COF86.662.3496.92
HBAN13.502.1214.74
CFG35.202.0639.75
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.20
Current Ratio 5.30
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -33.90
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-380.40
EBITDA Margin-368.90
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 8.29
PS Ratios 43.25
Price to Cash Flow 12.10
Price to Free Cash Flow -154.60
Cash Flow Per Share -0.06
Price to Tangible Book8.58
Book Value per Share2.15
Enterprise Value (in ths.)468 613
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -57.59
Return on Assets (5Y Avg) -
ROA last 12 Months -29.72
Return on Capital (5Y Avg) -
ROC last 12 Months -58.31
Return on invested Capital Q -16.95
Return on invested Capital Y-16.95
Assets Turnover0.00
Receivables Turnover7.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)15 043
Revenue per Share 0.41
Revenue Growth 3 Years 114.05
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2016-0.45-0.3913.33
Q03 2016-0.35-0.40-14.29
Q02 2016-0.41-0.394.88
Q01 2016-0.26-0.44-69.23
Q04 2015-0.34-0.39-14.71
Q03 2015-0.25-14.26-5 604.00
----
----
Earnings Per EndEstimateRevision %Trend
3/2017 QR-0.5270.62Positive
6/2017 QR-0.7874.68Positive
12/2017 FY-2.25--
12/2018 FY-2.47--
Next Report Date5th May 2017
Estimated EPS Next Report-0.60
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume67 340
Shares Outstanding (in ths.)36 570
Trades Count315
Dollar Volume991 998
Avg. Volume249 918
Avg. Weekly Volume488 946
Avg. Monthly Volume488 461
Avg. Quarterly Volume243 178

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

80%20%

Bearish Bullish

75%25%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.00

There are no comments yet.

News

Plus500
x